COLLOIDAL BISMUTH SUBCITRATE OR TRIPOTASSIUM DICITRATO BISMUTHATE
Background and Date of Approval
Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate is classified within the anti-ulcerant therapeutic class.
Uses
Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate is commonly used to treat various gastrointestinal disorders. Its primary applications include managing conditions such as gastritis, peptic ulcer disease, dyspepsia (indigestion), and reflux esophagitis.
How is it administered?
Tripotassium dicitrato bismuthate is typically administered orally. It is commonly available as a tablet or liquid suspension for oral ingestion. The best route of administration depends on the individual's needs and preferences, but oral administration is typically the most convenient.
Side Effects
Side effects of Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate may include both common and rare reactions. Common side effects can encompass a harmless darkening of the tongue and stool, as well as gastrointestinal disturbances like constipation or diarrhoea. On the other hand, rare but potentially severe side effects may include allergic reactions, presenting as skin rashes, itching, swelling, or difficulties in breathing.
Warnings
Prolonged or excessive use of Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate can lead to bismuth toxicity, which may manifest as symptoms like neurotoxicity, kidney damage, or other serious adverse effects. Although it is used to treat gastrointestinal conditions, it may mask symptoms of more serious underlying issues such as gastric malignancy.
Precautions
It is crucial to adhere to the recommended dosage of Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate and not exceed the prescribed duration of use. Thus, if symptoms of gastrointestinal conditions persist or worsen despite treatment, further investigation may be necessary.
Word of Advice
Patients with a known allergy to colloidal bismuth subcitrate or tripotassium dicitrato bismuthate and its components should not use this medication. Caution is warranted in patients with severe renal or hepatic impairment, as the medication may further compromise organ function. Pregnant or breastfeeding patients should avoid this medication without medical guidance. Caution is also advised in paediatric patients and those with pulmonary conditions. Alcohol consumption should be limited or avoided due to potential interaction with the drug. Patients should exercise caution when driving or operating machinery, as the medication may cause dizziness or drowsiness. Adherence to prescribed dosage and usage instructions is essential.
References
Burgundy Sweet, Upper Gastrointestinal Disorders, Handbook of Applied Therapeutics, 9th Edition, 2016, 245-256. I V Maev et al., Bismuth preparations in the treatment of patients with gastric and duodenal ulcer disease, Klin Med (Mosk), 2008, 86(9):57-63 [Accessed on 16th Oct 2023] https://pubmed.ncbi.nlm.nih.gov/19048841/ Thomas et al., Medical Use of Bismuth: the Two Sides of the Coin, J Clinic Toxicol, 2011, [Accessed on 16th Oct 2023] https://www.longdom.org/open-access/medical-use-of-bismuth-the-two-sides-of-the-coin-2161-0495.S3-004.pdf
Frequently Asked Questions
What are the common side effects of Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate?
Common side effects of Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate may include darkening of the tongue and stool and gastrointestinal disturbances such as constipation or diarrhoea.
Are there any dietary restrictions I should follow while taking Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate?
While there may not be specific dietary restrictions, it is advisable to consult a healthcare professional regarding any dietary considerations that may optimize the effectiveness of the medication and alleviate gastrointestinal symptoms.
Can I stop taking Tripotassium dicitrato bismuthate if I feel better?
It is important to complete the full course of medication as prescribed by your healthcare professional, even if symptoms improve. Discontinuing the medication prematurely may lead to a relapse of symptoms or incomplete recovery.
Is it safe to use Tripotassium dicitrato bismuthate for an extended period?
Prolonged use of Tripotassium dicitrato bismuthate should be done under the supervision of a healthcare professional to monitor for any potential complications or adverse effects.
How long does it take for Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate to show its effects?
The time it takes for Tripotassium dicitrato bismuthate to show its effects may vary depending on the individual and the treatment condition. Following the prescribed treatment regimen and consult a healthcare professional for any concerns about the medication's effectiveness is essential.
What should I do if I miss a dose of Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate?
If you miss a dose of Colloidal bismuth subcitrate or tripotassium dicitrato bismuthate, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.